These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4660731)

  • 1. Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia.
    Kojima R; Driscoll J; Mantel N; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):121-35. PubMed ID: 4660731
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of schedule of administration of mitomycin C (NSC-26980) in the treatment of L1210 leukemia.
    Kojima R; Goldin A; Mantel N
    Cancer Chemother Rep 2; 1972 Nov; 3(1):111-9. PubMed ID: 4660730
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies on the antitumor effect on intravenous administration of carbazilquinone and mitomycin-C.
    Okada N; Arakawa M
    Gan; 1976 Dec; 67(6):805-12. PubMed ID: 1021507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mitomycin analogs produced by directed biosynthesis.
    Claridge CA; Bush JA; Doyle TW; Nettleton DE; Moseley JE; Kimball D; Kammer MF; Veitch J
    J Antibiot (Tokyo); 1986 Mar; 39(3):437-46. PubMed ID: 3700245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-staphylococcal activities of mitomycin derivatives and its relationship to antileukemic effects].
    Kojima R
    Igaku To Seibutsugaku; 1972 Jan; 84(1):27-32. PubMed ID: 5065155
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract]   [Full Text] [Related]  

  • 7. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
    Panasci LC; Green D; Nagourney R; Fox P; Schein PS
    Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
    Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
    Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
    Arakawa M
    Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
    Relyveld EH; Bizzini B; Ophir R; Ben-Efraim S
    Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
    Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
    Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
    Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O/W emulsion.
    Sasaki H; Takakura Y; Hashida M; Kimura T; Sezaki H
    J Pharmacobiodyn; 1984 Feb; 7(2):120-30. PubMed ID: 6427444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.
    Nawrot-Modranka J; Ochocki J; Graczyk J
    Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of cyclophosphamide-treated leukaemia cells.
    Kawalec M; Jakóbisiak M; Skórski T; Kawiak J
    Folia Biol (Praha); 1982; 28(5):334-43. PubMed ID: 6816636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carbazilquinone on leukemic cell count in various tissues of mice bearing leukemia L-1210.
    Arakawa M; Okada N
    Gan; 1974 Feb; 65(1):21-5. PubMed ID: 4825388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K; Sekido S; Araki T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
    Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
    Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.